semaglutide patent expiration us 2031 New Delhi, March 19, 2026 – On Friday, the key on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy— expired in India, marking a pivotal shift in the country's New Delhi, March 20, 2026
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
New Delhi, March 20, 2026 The primary patent protecting semaglutide, the powerhouse ingredient in Novo Nordisk's globally renowned Ozempic and Wegovy, officially expired in India on Friday, March 20, 2026. This Novo Nordisk Settles Ozempic Patent Case CHIP LAW GROUP Novo's Ozempic Patent Expires Jan. 4 in Canada, But Generics Not Imminent Bloomberg India's generic semaglutide surge Opinion Chemistry World Peptide Biosimilars: What Happens When Semaglutide Patents Expire and What It Means for Access Meto blog Canada approves generic semaglutide from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent
Store: clickpoint.com.au · Domain: clickpoint.com.au




























